tradingkey.logo
tradingkey.logo
Search

Kalvista Pharmaceuticals Inc

KALV
Add to Watchlist
26.990USD
0.0000.00%
Close 07/02, 13:00ETQuotes delayed by 15 min
1.44BMarket Cap
LossP/E TTM

Kalvista Pharmaceuticals Inc Earnings Date

Period
FY2025 Earnings Date
Revenue(YoY)
49.08M
--
EPS(YoY)
-2.03
40.94%
Analyst Rating
2026-07-01

Financial Indicators

EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Income Statement

Revenue
Operating profit
Net Profit
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Balance Sheet

Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Cash Flow Statement

Net operating income
Net investment
Net financing
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

FAQs

What is the net investment of Kalvista Pharmaceuticals Inc?

According to Kalvista Pharmaceuticals Inc's FY2025 earnings report, its net investment of Kalvista Pharmaceuticals Inc was 18.68M, with a year-on-year change of 122.05.

What is the net financing of Kalvista Pharmaceuticals Inc?

According to Kalvista Pharmaceuticals Inc's FY2025 earnings report, its net financing of Kalvista Pharmaceuticals Inc was 162.64M, with a year-on-year change of 7.91.

What is the Earnings Per Share (EPS) of Kalvista Pharmaceuticals Inc?

According to Kalvista Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.03, with a year-on-year change of 40.94.

What is the Return on Equity (ROE) of Kalvista Pharmaceuticals Inc?

According to Kalvista Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -121.50, with a year-on-year change of -76.33.

What is the Return on Assets (ROA) of Kalvista Pharmaceuticals Inc?

According to Kalvista Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -75.46, with a year-on-year change of -24.72.

What is the operating profit of Kalvista Pharmaceuticals Inc?

According to Kalvista Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -112.04M, with a year-on-year change of 20.23.